• ABL Diagnostics reported its liquidity contract with AllInvest Securities held 33,993 shares, EUR 76,654.75 in cash at June 30, 2026.
• During the first half of 2026, the liquidity provider bought 106,097 shares for EUR 355,665.92 across 1,599 trades.
• It sold 116,652 shares for EUR 415,860.90 across 1,750 trades, implying net sales of 10,555 shares over the period.
• Resources at Dec. 31, 2025 were 44,548 shares, EUR 16,167.24 in cash.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABL Diagnostics SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260712524974) on July 13, 2026, and is solely responsible for the information contained therein.